153 related articles for article (PubMed ID: 10711353)
1. The group II metabotropic glutamate receptor agonist, DCG-IV, alleviates akinesia following intranigral or intraventricular administration in the reserpine-treated rat.
Dawson L; Chadha A; Megalou M; Duty S
Br J Pharmacol; 2000 Feb; 129(3):541-6. PubMed ID: 10711353
[TBL] [Abstract][Full Text] [Related]
2. Activation of group III metabotropic glutamate receptors in selected regions of the basal ganglia alleviates akinesia in the reserpine-treated rat.
MacInnes N; Messenger MJ; Duty S
Br J Pharmacol; 2004 Jan; 141(1):15-22. PubMed ID: 14597605
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective effects of group II metabotropic glutamate receptor agonist DCG-IV on hippocampal neurons in transient forebrain ischemia.
Yoshioka H; Sugita M; Kinouchi H
Neurosci Lett; 2009 Sep; 461(3):266-70. PubMed ID: 19549561
[TBL] [Abstract][Full Text] [Related]
4. Anticonvulsive and neuroprotective actions of a potent agonist (DCG-IV) for group II metabotropic glutamate receptors against intraventricular kainate in the rat.
Miyamoto M; Ishida M; Shinozaki H
Neuroscience; 1997 Mar; 77(1):131-40. PubMed ID: 9044381
[TBL] [Abstract][Full Text] [Related]
5. GABA(B) receptor agonists reverse akinesia following intranigral or intracerebroventricular injection in the reserpine-treated rat.
Johnston T; Duty S
Br J Pharmacol; 2003 Aug; 139(8):1480-6. PubMed ID: 12922935
[TBL] [Abstract][Full Text] [Related]
6. Anticonvulsant and glutamate release-inhibiting properties of the highly potent metabotropic glutamate receptor agonist (2S,2'R, 3'R)-2-(2',3'-dicarboxycyclopropyl)glycine (DCG-IV).
Attwell PJ; Singh Kent N; Jane DE; Croucher MJ; Bradford HF
Brain Res; 1998 Sep; 805(1-2):138-43. PubMed ID: 9733953
[TBL] [Abstract][Full Text] [Related]
7. Neurotoxicity of (2S,1'R,2'R,3'R)-2-(2,3-dicarboxycyclopropyl)glycine, a potent agonist for class II metabotropic glutamate receptors, in the rat.
Kwak S; Miyamoto M; Ishida M; Shinozaki H
Neuroscience; 1996 Aug; 73(3):687-95. PubMed ID: 8809790
[TBL] [Abstract][Full Text] [Related]
8. Activation of group II mGlu receptors inhibits voltage-gated Ca2+ currents in myenteric neurons.
Chen WP; Kirchgessner AL
Am J Physiol Gastrointest Liver Physiol; 2002 Dec; 283(6):G1282-9. PubMed ID: 12388194
[TBL] [Abstract][Full Text] [Related]
9. DCG-IV but not other group-II metabotropic receptor agonists induces microglial BDNF mRNA expression in the rat striatum. Correlation with neuronal injury.
Venero JL; Santiago M; Tomás-Camardiel M; Matarredona ER; Cano J; Machado A
Neuroscience; 2002; 113(4):857-69. PubMed ID: 12182892
[TBL] [Abstract][Full Text] [Related]
10. Characterization of [3H]-(2S,2'R,3'R)-2-(2',3'-dicarboxy-cyclopropyl)glycine ([3H]-DCG IV) binding to metabotropic mGlu2 receptor-transfected cell membranes.
Cartmell J; Adam G; Chaboz S; Henningsen R; Kemp JA; Klingelschmidt A; Metzler V; Monsma F; Schaffhauser H; Wichmann J; Mutel V
Br J Pharmacol; 1998 Feb; 123(3):497-504. PubMed ID: 9504391
[TBL] [Abstract][Full Text] [Related]
11. Metabotropic glutamate receptor antagonists and agonists: potential neuroprotectors in diffuse brain injury.
Fei Z; Zhang X; Bai HM; Jiang XF; Wang XL
J Clin Neurosci; 2006 Dec; 13(10):1023-7. PubMed ID: 17113985
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the mGluR2/3 agonist LY379268 in rodent models of Parkinson's disease.
Murray TK; Messenger MJ; Ward MA; Woodhouse S; Osborne DJ; Duty S; O'Neill MJ
Pharmacol Biochem Behav; 2002 Sep; 73(2):455-66. PubMed ID: 12117601
[TBL] [Abstract][Full Text] [Related]
13. Activation of spinal metabotropic glutamate receptors elicits cardiovascular responses in pentobarbital anesthetized rats.
Celuch SM; García Mdel C
Naunyn Schmiedebergs Arch Pharmacol; 2002 Oct; 366(4):343-9. PubMed ID: 12237748
[TBL] [Abstract][Full Text] [Related]
14. Regulation of phosphoinositide turnover in neonatal rat cerebral cortex by group I- and II- selective metabotropic glutamate receptor agonists.
Mistry R; Golding N; Challiss RA
Br J Pharmacol; 1998 Feb; 123(3):581-9. PubMed ID: 9504400
[TBL] [Abstract][Full Text] [Related]
15. Protection against acute amphetamine-induced behavior by microinjection of a group II metabotropic glutamate receptor agonist into the dorsal striatum of rats.
Mao L; Wang JQ
Neurosci Lett; 1999 Jul; 270(2):103-6. PubMed ID: 10462108
[TBL] [Abstract][Full Text] [Related]
16. Antiparkinsonian potential of targeting group III metabotropic glutamate receptor subtypes in the rodent substantia nigra pars reticulata.
Broadstock M; Austin PJ; Betts MJ; Duty S
Br J Pharmacol; 2012 Feb; 165(4b):1034-45. PubMed ID: 21627638
[TBL] [Abstract][Full Text] [Related]
17. The metabotropic glutamate receptor 8 agonist (S)-3,4-DCPG reverses motor deficits in prolonged but not acute models of Parkinson's disease.
Johnson KA; Jones CK; Tantawy MN; Bubser M; Marvanova M; Ansari MS; Baldwin RM; Conn PJ; Niswender CM
Neuropharmacology; 2013 Mar; 66():187-95. PubMed ID: 22546615
[TBL] [Abstract][Full Text] [Related]
18. Attenuation of seizures induced by homocysteic acid in immature rats by metabotropic glutamate group II and group III receptor agonists.
Folbergrová J; Haugvicová R; Mares P
Brain Res; 2001 Jul; 908(2):120-9. PubMed ID: 11454322
[TBL] [Abstract][Full Text] [Related]
19. Direct and indirect interactions between cannabinoid CB1 receptor and group II metabotropic glutamate receptor signalling in layer V pyramidal neurons from the rat prefrontal cortex.
Barbara JG; Auclair N; Roisin MP; Otani S; Valjent E; Caboche J; Soubrie P; Crepel F
Eur J Neurosci; 2003 Mar; 17(5):981-90. PubMed ID: 12653974
[TBL] [Abstract][Full Text] [Related]
20. (2S,1'R,2'R,3'R)-2-(2,3-dicarboxycyclopropyl) glycine positively modulates metabotropic glutamate receptors coupled to polyphosphoinositide hydrolysis in rat hippocampal slices.
Genazzani AA; L'Episcopo MR; Casabona G; Shinozaki H; Nicoletti F
Brain Res; 1994 Oct; 659(1-2):10-6. PubMed ID: 7820650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
